Cargando…
Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature
BACKGROUND: Congenital cytomegalovirus (cCMV) infection is an important illness that is a common cause of hearing loss in newborn infants and a major cause of disability in children. For that reason, treatment of symptomatic patients with either ganciclovir or its pro-drug valganciclovir is recommen...
Autores principales: | Morillo-Gutierrez, Beatriz, Waugh, Sheila, Pickering, Ailsa, Flood, Terence, Emonts, Marieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567904/ https://www.ncbi.nlm.nih.gov/pubmed/28830465 http://dx.doi.org/10.1186/s12887-017-0933-6 |
Ejemplares similares
-
Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
por: Di Cristanziano, Veronica, et al.
Publicado: (2021) -
Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017) -
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
por: Hakki, Morgan
Publicado: (2020) -
Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
por: Holmes-Liew, Chien-Li, et al.
Publicado: (2015) -
1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
por: Khurana, Mark Poulsen, et al.
Publicado: (2018)